Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype

BACKGROUND: The efficacy of cell transplantation in heart failure is reportedly modest, but adjuvant drugs combined with cell therapy may improve this efficacy. Peroxisome proliferator-activated receptor (PPAR)γ, one of the hypoglycemic medicine for diabetes mellitus, reportedly enhances cytokine pr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cardiovasc Diabetol
Auteurs principaux: Mori, Daisuke, Miyagawa, Shigeru, Matsuura, Ryohei, Sougawa, Nagako, Fukushima, Satsuki, Ueno, Takayoshi, Toda, Koichi, Kuratani, Toru, Tomita, Koichi, Maeda, Norikazu, Shimomura, Iichiro, Sawa, Yoshiki
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6431071/
https://ncbi.nlm.nih.gov/pubmed/30902059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0829-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires